Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Sucampo Pharmaceuticals, Inc.    SCMP

SUCAMPO PHARMACEUTICALS, INC. (SCMP)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesNewsAnalysisCompany 
Company
Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development, identification, acquisition, and delivery of innovative pharmaceutical products.It operates through the following geographic segments: Asia, the Americas, and Europe.It offers Lubiprostone, which treats... 
More about the company
Latest news on SUCAMPO PHARMACEUTICALS, I
02/15MALLINCKRODT : Completes Acquisition Of Sucampo Pharmaceuticals, Inc.
AQ
01/25MONTEVERDE & ASSOCIATES PC : Files Class Action Lawsuit On Behalf Of Shareholder..
PR
01/22SUCAMPO PHARMACEUTICALS : SCMP) Andrews & Springer LLC Is Investigating Sucampo..
BU
01/11SUCAMPO PHARMACEUTICALS : Wolf Popper LLP Investigates the Proposed Acquisition ..
AQ
01/04MALLINCKRODT : To Acquire Sucampo Pharmaceuticals For Approximately $1.2 Billion
AQ
01/03Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Whethe..
BU
01/02SUCAMPO PHARMACEUTICALS, INC. : Other Events (form 8-K)
AQ
01/01Monteverde & Associates PC Announces An Investigation Of Sucampo Pharmaceutic..
PR
2017SUCAMPO PHARMACEUTICALS, INC. Former SEC Attorney Willie Briscoe Investigates..
BU
2017MALLINCKRODT : to Acquire Sucampo Pharmaceuticals for Approximately $1.2 Billion
AQ
More news
Sector news : Bio Therapeutic Drugs
07/09LONZA : restates 2017 figures after changing accounting standard
RE
07/03Sanofi beefs up diabetes pipeline to retrieve success
RE
06/29European stocks shrug off trade worries with quarterly gain
RE
06/29GILEAD SCIENCES : Rival Novartis, Gilead CAR-T therapies win European panel reco..
RE
06/20GILEAD SCIENCES : GSK takes billion-dollar drug fight with Gilead to top AIDS me..
RE
More sector news : Bio Therapeutic Drugs
4-Traders Strategies on SUCAMPO PHARMACEUTICALS, I 
SUCAMPO PHARMACEUTICALS - 2015
The bullish trend is not over
BUY
More Strategies
News from SeekingAlpha
03/01MALLINCKRODT : Can The Upside Trump This Pertinent Risk? 
02/20Tracking John Paulson's Paulson & Company Portfolio - Q4 2017 Update 
02/06REI, JRVR, EVTC gain on SmallCap 600 entries 
02/02Barclays bearish on Mallinckrodt on Acthar reimbursement pressure & tepid out.. 
01/26Premarket analyst action - healthcare 
Managers
NameTitle
Peter P. Pfreundschuh Chief Financial Officer
Peter Lichtlen Chief Medical Officer
Maureen E. O'Connell Independent Director
Robert Jay Spiegel Independent Director
Paul R. Edick Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
SUCAMPO PHARMACEUTICALS, INC.0.28%0
GILEAD SCIENCES7.84%100 614
VERTEX PHARMACEUTICALS20.45%45 997
REGENERON PHARMACEUTICALS-2.21%38 951
GENMAB5.93%10 467
NEUROCRINE BIOSCIENCES, INC.32.61%9 250